Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aldosterone and thrombosis formation: implications for ischemic and atherosclerotic heart disease.

× No keyword cloud information.

13 in total

1. From inflammation to fibrosis: a stiff stretch of highway.

Authors: Karl T Weber
Journal: Hypertension Date: 2004-02-16 Impact factor: 10.190

2. Rapid effects of aldosterone: relevant in cardiac ischemia?

Authors: Martin Wehling
Journal: Hypertension Date: 2005-06-13 Impact factor: 10.190

3. Aldosterone promotes thrombosis formation after arterial injury in mice.

Authors: P F Bodary; C Sambaziotis; K J Wickenheiser; S Rajagopalan; B Pitt; D T Eitzman
Journal: Arterioscler Thromb Vasc Biol Date: 2006-01 Impact factor: 8.311

4. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Authors: Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad
Journal: J Am Coll Cardiol Date: 2005-04-19 Impact factor: 24.094

Review 5. Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001.

Authors: K Huber; G Christ; J Wojta; D Gulba
Journal: Thromb Res Date: 2001-09-30 Impact factor: 3.944

6. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors: Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal: N Engl J Med Date: 2003-03-31 Impact factor: 91.245

7. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors: B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal: N Engl J Med Date: 1999-09-02 Impact factor: 91.245

8. Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes.

Authors: Lorenzo A Calò; Francesca Zaghetto; Elisa Pagnin; Paul A Davis; Paola De Mozzi; Paola Sartorato; Giuseppe Martire; Cristina Fiore; Decio Armanini
Journal: J Clin Endocrinol Metab Date: 2004-04 Impact factor: 5.958

9. Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice.

Authors: Shlomo Keidar; Tony Hayek; Marielle Kaplan; Elsa Pavlotzky; Shadi Hamoud; Raymond Coleman; Michael Aviram
Journal: J Cardiovasc Pharmacol Date: 2003-06 Impact factor: 3.105

10. Characterization of aldosterone binding sites in circulating human mononuclear leukocytes.

Authors: D Armanini; T Strasser; P C Weber
Journal: Am J Physiol Date: 1985-03

1 in total

1. Effect of canrenone and amiloride on the prooxidative effect induced by aldosterone in human mononuclear leukocytes in vitro.

Authors: C Fiore; P Sartorato; E Pagnin; E Ragazzi; L A Calò; D Armanini
Journal: J Endocrinol Invest Date: 2009-05-21 Impact factor: 4.256

1 in total